To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

[Interferon-alpha can imp… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

[Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate]

Journal article
Authors Örjan Strannegård
Fredrik Bergh Thorén
Erik Lundgren
Published in Läkartidningen
Volume 105
Issue 6
Pages 358-61
ISSN 0023-7205
Publication year 2008
Published at Institute of Biomedicine, Department of Infectious Medicine
Pages 358-61
Language en
Keywords Antineoplastic Agents, Alkylating, therapeutic use, Combined Modality Therapy, Dacarbazine, therapeutic use, Disease Progression, Humans, Immunologic Factors, therapeutic use, Interferon-alpha, therapeutic use, Melanoma, drug therapy, mortality, surgery, therapy, Survival Rate, Treatment Outcome
Subject categories Tumour immunology
Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?